» Articles » PMID: 17494842

Hepatocellular Carcinoma with Internal Mammary Artery Supply: Feasibility and Efficacy of Transarterial Chemoembolization and Factors Affecting Patient Prognosis

Overview
Date 2007 May 15
PMID 17494842
Citations 7
Authors
Affiliations
Soon will be listed here.
Abstract

Purpose: To determine technical feasibility, therapeutic efficacies, and identify prognostic factors in patients with hepatocellular carcinoma (HCC) treated by transarterial chemoembolization via the internal mammary artery.

Materials And Methods: From August 1996 to July 2005, the authors identified the internal mammary arteries supplying HCCs in 97 (2.2%) of 4,438 HCC patients. Computed tomography scans and digital subtraction angiography images of these 97 patients were retrospectively reviewed by consensus between two of the authors regarding technical success and clinical outcome. The technical success of internal mammary artery chemoembolization was defined as achievement of catheterization into feeding vessels, delivery of drugs via those vessels, and no residual tumor staining fed by the internal mammary artery. Multivariate Cox proportional hazard regression analysis was performed to enable evaluation of prognostic factors for survival.

Results: Technical success by selective chemoembolization via internal mammary artery was achieved in 53 (55%) of the 97 patients. The clinical responses of the 97 patients were complete remission (n=3), partial remission (n=19), no response (n=65), and no available follow-up image (n=10). Overall cumulative survival rates, calculated from times of internal mammary artery chemoembolization, were 55.9% (at 6 months), 32.5% (at 1 year), 15.4% (at 2 years), and 8.2% (at 3 years). Multivariate analysis showed that tumor multiplicity (single vs multiple nodular or diffuse; P=.013), portal vein thrombosis (P=.004), and the technical success of internal mammary artery chemoembolization (P=.02) each significantly affected survival.

Conclusions: Although patients with HCC supplied by the internal mammary artery had poor prognosis because of their advanced stage of disease, chemoembolization via the internal mammary artery is possible and worth performing in selective situations.

Citing Articles

Common trunk of the internal thoracic artery, inferior thyroid artery and thyrocervical trunk from the subclavian artery: a rare arterial variant.

Westrych K, Ruzik K, Zielinska N, Paulsen F, Georgiev G, Olewnik L Surg Radiol Anat. 2022; 44(7):983-986.

PMID: 35792911 DOI: 10.1007/s00276-022-02977-w.


Successful Transcatheter Arterial Radioembolization of Hepatocellular Carcinoma Via Left Internal Mammary Artery: A Case Report.

Alhussaini A, Qazi S, AlZahrani Y Cureus. 2022; 14(3):e22954.

PMID: 35411262 PMC: 8988898. DOI: 10.7759/cureus.22954.


Intra- and Extrahepatic Collaterals: Pitfalls and Pathways for Locoregional Therapy.

Su J, Kapoor S, Brown D Semin Intervent Radiol. 2018; 35(1):69-80.

PMID: 29628619 PMC: 5886773. DOI: 10.1055/s-0038-1636523.


Role of Transcatheter Intra-arterial Therapies for Hepatocellular Carcinoma.

Paul S, Sharma H J Clin Exp Hepatol. 2015; 4(Suppl 3):S112-21.

PMID: 25755602 PMC: 4284218. DOI: 10.1016/j.jceh.2014.03.048.


Clinical features of hepatocellular carcinoma supplied by the left internal mammary artery.

Miyayama S, Yamashiro M, Hashimoto M, Yoshida M, Hashimoto N, Ikuno M Jpn J Radiol. 2012; 30(10):798-805.

PMID: 22956343 DOI: 10.1007/s11604-012-0123-2.